Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Atrophy

• A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy
• Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy
• A Comparison of Hyaluronic Acid and Estradiol Treatment in Vulvovaginal Atrophy.
• A Study to Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy
• Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy
• A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy
• Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).
• Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes
• Biomarker Study of ATH434 in Participants With MSA
• A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
• A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
• A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
• A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
• A Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy
• Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic Gastritis
• Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy
• Phase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD)
• Biomarker Study of ATH434 in Participants With MSA
• Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early- to Moderate Stage MSA
• Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
• Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA)
• Simultaneous Versus Sequential Fractional CO2 Laser and Subcision Combination for Post-acne Atrophic Scars: A Split-face Comparative Study.
• Effects of Vaginal Oxytocin Gel on Vaginal Cytologic Parameters in Postmenopausal Woman
• Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab-ONYX
• Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy
• Microneedling With Topical Preparations in the Treatment of Atrophic Post-acne Scars
• Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women
• Comparing the Efficacy of Topical Tazarotene Gel 0.1% v/s Microneedling in Atrophic Post Acne Scars
• GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.
• Open-Label Extension for Subjects Who Previously Completed Phase 3 Study ISEE2008.
• A Study of TAK-341 in Treatment of Multiple System Atrophy
• Risdiplam in Patients With Spinal Muscular Atrophy Previously Treated With Nusinersen
• A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients
• Clinical Study of Manpixiao in the Treatment of Chronic Atrophic Gastritis
• Postpartum Vaginal Estrogen
• A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women
• Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA
• Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy
• Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser
• Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
• Proof of Mechanism Study to Evaluate Binding of Alfa-synuclein
• Long-Term Follow-Up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)
• Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.
• Efficacy and Safety of Using Granules Dendrobii for the Treatment of Chronic Atrophic Gastritis
• Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic Atrophy Secondary to dAMD
• Phase 3 Active Treatment Trial to Evaluate the Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Who Are Being Treated With Nusinersen or Risdiplam
• Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis
• A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Ambulatory Children With Spinal Muscular Atrophy
• Study of ATH434 in Participants With Multiple System Atrophy
• A Study of Lu AF82422 in Participants With Multiple System Atrophy
• Umbilical Cord Plasma for Treating Endometrial Pathologies (Thin Endometrium / Asherman's Syndrome/ Endometria Atrophy)
• A Study to Evaluate Higher Dose (HD) Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy Previously Treated With Risdiplam
• A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
• A Clinical Study of Intravaginal Prasterone (Intrarosa®) in Postmenopausal Vulvovaginal Atrophy
• Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain
• Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo
• An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD
• ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration
• Zoledronic Acid for Prevention of Bone Loss After BAriatric Surgery (ZABAS)
• Vulvovaginal Atrophy Correction Using Neodymium Laser
• Extension Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy Who Previously Participated in a Study With Nusinersen
• Bioavailability and Bioequivalence of Two Risdiplam Tablets in Healthy Participants
• Comparative Study: Vaginal Promestriene Use, Fractional CO2 LASER and Radiofrequency in the Vaginal Atrophy Treatment
• A Clinical Pharmacology Study to Evaluate the Effect of GYM329 on Disuse Muscle Atrophy in Healthy Volunteer
• Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors
• Systemic Erythropoietin Injection in Patients Having Optic Atrophy
• Evaluating the Efficacy of Temperature-controlled Radiofrequency (TRF) in the Treatment of Vulvovaginal Atrophy.
• A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy
• A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration
• Study to Evaluate Efficacy of Vagitocin in Postmenopausal Women With Vulvovaginal Atrophy Symptoms
• Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7303359 in Participants With Geographic Atrophy
• A Study Assessing the Long-Term Safety and Tolerability of FHTR2163 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
• Study of the Functional Effects of Nusinersen in 5q-spinal Muscular Amyotrophy Adults (SMA Type 2 or 3 Forms)
• Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.
• Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors
• A Study of Nusinersen Among Participants With Spinal Muscular Atrophy Who Received Onasemnogene Abeparvovec
• Photobiomodulation Effect on Vulvovaginal Atrophy in Postmenopausal Women.
• Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study
• A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)
• Exenatide Once-weekly as a Treatment for Multiple System Atrophy
• Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
• Long-Term Analysis of DImethyl Fumarate, to Slow the Growth of Areas of Geographic Atrophy
• [18F]F-DOPA Imaging in Patients With Autonomic Failure
• Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream
• Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With VVA
• Efficacy of Saline Injection Therapy in Atrophic Acne Scars
• A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients
• Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA)
• Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB101 Administered to Adults With Multiple System Atrophy
• A Randomized Controlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal Atrophy
• Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy
• LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2)
• Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial
• Cyanoacrylate With Sutures for Fixation of Free Gingival Graft
• E-CEL UVEC Cells as an Adjunct Cell Therapy for the Arthroscopic Rotator Cuff Repair in Adults
• Pulmonary Function Test Changes and Respiratory Muscle Strength Trends in Spinal Muscular Atrophy Patients Receiving Nusinersen Treatments
• LASER and Radiofrequency and Genitourinary Syndrome of Menopause
• Rituximab for Multiple System Atrphy
• A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy
• Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy
• A Drug-drug Interaction Study With Risdiplam Multiple Dose and Midazolam in Healthy Participants
• A Study Assessing the Safety, Tolerability, and Efficacy of RG6147 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)
• Study of BHV-3241 in Subjects With Multiple System Atrophy
• Trial of Parkinson's And Zoledronic Acid
• A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics and Safety and Tolerability of a Single Oral Dose of Risdiplam Compared to Matched Healthy Participants With Normal Hepatic Function
• Tllsh2910 for Ataxia and Gut Microbiota Alteration in Patients of Multiple System Atrophy
• New Non-Hormonal Treatment by Radiofrequency for Vulvo-Vaginal Atrophy
• Phase 3 Study of ALK-001 in Geographic Atrophy
• Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3
• GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)
• Clinical Study of Weifuchun Treatment on Precancerous Lesions of Gastric Cancer
• Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy
• Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients
• A Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy
• Study to Evaluate the Safety of Intravitreal APL-2 in Patients Diagnosed With Geographic Atrophy
• Safinamide for Multiple System Atrophy (MSA)
• Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer
• Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment
• Clinical Laboratory Evaluation of Chronic Autonomic Failure
• A Futility Trial of Sirolimus in Multiple System Atrophy
• A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
• Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
• Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function
• Automated Abdominal Binder for Orthostatic Hypotension
• Carbidopa-Levodopa in Dry AMD With Geographic Atrophy
• Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism
• Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
• Inosine 5'-Monophosphate to Raise of Serum Uric Acid Level in Patients With Multiple System Atrophy: a Multi-center, Randomized Controlled, Double Blind, Parallel Assigned Clinical Trial
• Study to Evaluate Estradiol Vaginal Tablets vs Promestriene Vaginal Cream
• Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy
• Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
• Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis
• Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year
• Visnadine, Prenylflavonoids and Bovine Colostrum to Treat Vulvovaginal Atrophy in Postmenopausal Women
• The Impact of N-Acetylcysteine on Volumetric Retention of Autologous Fat Graft for Breast Asymmetry Correction
• A Study of the Safety and Tolerability of ASP7317 in Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
• Comparison Between Microneedling Daycare Procedure and Tazarotene 0.1% Gel Local Application in Acne Scarring
• Role of Metformin on Muscle Health of Older Adults
• Novel Compositions for Treating or Preventing Dermal Disorders
• The Effects of 17β-estradiol on Skeletal Muscle
• Systemic Hormones and Muscle Protein Synthesis
• Investigation of Non-inferiority of Treatment of Vulvovaginal Dryness With WO2085 Moisturising Cream in Comparison to a Cream With 0.1% Estriol
• Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease
• A Study of Risdiplam (RO7034067) in Adult and Pediatric Participants With Spinal Muscular Atrophy
• A Multi-Site Study Comparing Estradiol Vaginal Cream (0.01%) to Estrace® Cream (0.01%) in Postmenopausal Females With Atrophic Vaginitis
• Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy
• The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis
• SPACE Trial: Pyridostigmine vs Placebo in SMA Types 2, 3 and 4
• Trial of Essential Amino Acid Supplementation in Protein Deficient Patients Following Total Knee Arthroplasty
• Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants
• Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
• Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)
• Sustainability of Vaginal Estrogen Therapy in Postmenopausal Women
• Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
• Effect of Low-Dose Celecoxib on SMN2 in Patients With Spinal Muscular Atrophy
• Expanded Access Program (EAP) for Nusinersen in Participants With Infantile-onset (Consistent With Type 1) Spinal Muscular Atrophy (SMA)
• A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome
• Norepinephrine Transporter Blockade, Autonomic Failure
• Effect of N-Acetylcysteine on Autologous Fat Graft Survival
• Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA
• Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia
• Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy
• Reconstruction of Jaw Bone Using Mesenchymal Stem Cells
• Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
• Molecular and Structural Imaging in Atypical Alzheimer's Disease: A Longitudinal Study
• Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars
• The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis
• Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic
• TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
• Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy
• Zimura in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
• Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD
• A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy
• To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.
• A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy
• A Study of CK-2127107 in Patients With Spinal Muscular Atrophy
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Risdiplam (RO7034067) Given by Mouth in Healthy Volunteers
• A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Patients With Spinal Muscular Atrophy (SMA)
• Alpha Lipoic Acid in Geographic Atrophy
• A Study for Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in Nusinersen (ISIS 396443) Investigational Studies.
• Evaluate the Efficacy, Safety and Tolerability of a Non-hormonal Intravaginal Gel in Postmenopausal Women With Symptoms of Vaginal Dryness.
• LPD+α-ketoacids on Autophagy and Improving Muscle Wasting in CKD
• Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration
• The Vaginal Health Trial
• CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA)
• Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy
• An Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy
• Fat Grafting and Retention for Heel Fat Pad Atrophy
• A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA).
• Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy
• TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy
• Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
• Evaluation of rGH Therapy to Prevent Muscle Atrophy in Patients With ACL Tears
• Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy
• A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting
• A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin
• AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
• A Study of Multiple Doses of Nusinersen (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy
• The Effect of Nandrolone Decanoate and Leucine on Muscle Loss
• Geographic Atrophy and Intravitreal Ranibizumab Injections
• A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin
• Vaginal Creams to Reduce Vaginal Erosion in Pessary Users
• Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of AV and DIV
• A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
• Tau Imaging in Young Onset Dementia
• A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy
• An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)
• Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
• A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
• A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
• Botulinum-assisted Orbital Fat Augmentation With PRP (Platelet-rich-plasma)
• A Study of RO6885247 in Adult and Pediatric Patients With Spinal Muscular Atrophy (MOONFISH)
• Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3
• 2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism
• A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis
• A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy
• Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea
• Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery
• Water and Sudafed in Autonomic Failure
• Laboratory Characteristics in Chronic Atrophic Acrodermatitis
• Mechanistic Approach to Preventing Atrophy and Restoring Function in Older Adults
• Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
• A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD Patients
• A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
• Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA
• Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.
• An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in ISIS 396443-CS2 (NCT01703988) or ISIS 396443-CS10 (NCT01780246)
• Myobloc Atrophy Study
• Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers
• Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
• Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic Vaginitis
• Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause
• Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach
• Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women
• A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin
• Cedar Honey in Oral Lichen Planus
• A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
• Topical DHEA Against Vaginal Atrophy
• Study to Evaluate Safety & Efficacy of WC3011 in Postmenopausal Women With Dyspareunia
• A Study to Assess the Efficacy, Safety and Pharmacokinetics of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy (SMA)
• Multicenter Study to Evaluate Safety and Efficacy of WC3011 in Postmenopausal Women
• Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride
• Fat Grafting for Pedal Fat Pad Atrophy
• Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
• An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1 (NCT01494701)
• Efficacy and Safety Of Spil's Estradiol Vaginal Tablet
• Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD
• An Open-label Safety, Tolerability and Dose-Range Finding Study of Multiple Doses of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy
• Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy
• Valproate and Levocarnitine in Children With Spinal Muscular Atrophy
• Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients
• A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)
• An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy
• Testosterone Administration and ACL Reconstruction in Men
• Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus
• Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus
• Evaluation of the Subjective and Objective Painful Threshold in Multiple System Atrophy Pain and Multiple System Atrophy
• Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction
• Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment
• Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)
• Safety Study of HPP593 in Subjects During and After Limb Immobilization
• Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency
• An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
• Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis
• To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG)
• Evaluate Long-Term Safety and Efficacy WC3011
• Sirolimus for Advanced Age-Related Macular Degeneration
• YF476 and Type I Gastric Carcinoids (Norway)
• Study of Oxytocin to Treat Vaginal Atrophy in Postmenopausal Women
• Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy
• Safety & Efficacy WC3011 in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women
• Therapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen Planus
• Study to Assess the Efficacy and Safety of Ibuprofen 50 mg/g Gel Compared to Profenid 25mg/g Gel
• Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients
• A Study of LY2495655 in Older Participants Undergoing Elective Total Hip Replacement
• Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy
• Upper Facial Remodeling With Perlane-L and Dysport
• Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
• YF476 and Type I Gastric Carcinoids
• Postpartum Dyspareunia Resulting From Vaginal Atrophy
• Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.
• Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
• Study of Rifampicin in Multiple System Atrophy
• DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
• DHEA Against Vaginal Atrophy - Safety Study of 12 Months
• A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic Atrophy
• Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars
• Fluoxetine in Multiple System Atrophy Patients
• Investigation of the Serotoninergic System in Multiple System Atrophy: a Positron Emission Tomography (PET) Study
• The Role of Endothelin in the Supine Hypertension of Autonomic Failure
• A Phase I Open Label Dose Escalation Trial of RNA-144101 in the Treatment of Geographic Atrophy
• Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis
• Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients
• Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) Study
• Nebivolol in the Supine Hypertension of Autonomic Failure
• A Clinical Study to Assess the Effects of SRT2104 Upon Immobilization-Induced Skeletal Muscle Atrophy in Healthy Human Volunteers
• Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy
• Lithium in Multiple System Atrophy
• Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)
• A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of FCFD4514S in Patients With Geographic Atrophy
• A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days
• Geographic Atrophy Treatment Evaluation
• A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease
• Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy
• Botulinum A Toxin in Patients With Parkinson's Disease
• A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis
• The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse
• Fipamezole in Neurogenic Orthostatic Hypotension
• Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins
• Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
• Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome Syndrome
• Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity
• Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids
• Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy
• CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I
• Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD)
• A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women
• Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients
• A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients
• A Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy Patients
• A Clinical Study to Evaluate the Safety of Ospemifene
• Augmenting Effects of L-DOPS With Carbidopa and Entacapone
• Pilot Study of Growth Hormon to Treat SMA Typ II and III
• Study to Evaluate Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy
• A Randomized, Double-blind, Placebo-controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON)
• A Trial of Hydroxyurea in Spinal Muscular Atrophy
• The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)
• Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy
• 5-Alpha Reductase and Anabolic Effects of Testosterone
• Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis
• Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial
• VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women
• Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III
• Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I
• Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis
• Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
• DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy
• Efficacy of TCA Effect on Varicella Atrophic Scars
• Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular Atrophy
• A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy
• OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration
• Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)
• A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
• Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause
• Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy
• Clinical Trial of Lamotrigine to Reverse Cognitive Impairment in Chronic Corticosteroid-Treated Patients
• Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)
• A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy
• Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis
• Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy
• Study About Efficacy and Safety to Treat Multi-System-Atrophy
• Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis
• Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms
• Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy
• Physiologic Effects of PRMS & Testosterone in the Debilitated Elderly
• Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease